dacarbazine and Cancer of Ovary

dacarbazine has been researched along with Cancer of Ovary in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19904 (18.18)18.7374
1990's6 (27.27)18.2507
2000's9 (40.91)29.6817
2010's2 (9.09)24.3611
2020's1 (4.55)2.80

Authors

AuthorsStudies
Coleman, RL; Demetri, GD; Herzog, TJ; Hu, P; Jones, RL; Knoblauch, R; McGowan, T; Monk, BJ; Patel, SR; Schuetze, SM; Shalaby, W; Triantos, S; Van Tine, BA; von Mehren, M1
Chang, M; Chen, TC; Geng, X; Liu, L; Song, X; Wang, W; Wang, X; Xie, L1
Huang, SC; Wu, PC; Yue, CT1
Jones, C; Plummer, ER1
Argenta, PA; Blair Harkness, C; Boente, MP; Carson, LF; Downs, LS; Judson, PL1
Barvaux, VA; Gillum, AM; Lorigan, P; Margison, GP; McElhinney, RS; McMurry, TB; Ranson, M1
Bookman, MA; Gallo, JM; Guo, P; Li, S; Ma, J; Orlansky, A; Pulfer, S; Vicini, P; Zhou, F1
Ball, HG; Chen, AH; Li, C; Quesenberry, CD; Zweizig, SL1
Duncan, T; Lindahl, T; Paik, J; Sedgwick, B1
Fishel, ML; He, Y; Kelley, MR; Smith, ML1
D'Incalci, M; Damia, G; Erba, E; Garattini, S; Morasca, L; Torti, L1
Barlow, JJ; DeEulis, TG; Lele, SB; Piver, MS1
Greenberg, S; Patsner, B1
Koĭnov, K; Tsvekova, V; Velikova, M1
Egorova, NI; Garin, AM; Gorozhanskaia, EG; Koroleva, EIu; Kushlinskiĭ, NE; Larionova, VB1
Chan, TH; Damian, Z; De Marte, J; Jean-Claude, BJ; Leyland-Jones, B; Mustafa, A; Vasilescu, DE; Yen, R1
Calvert, AH; Curtin, NJ; Delaney, CA; Durkacz, BW; Hostomsky, Z; Kyle, S; Newell, DR; Wang, LZ; White, AW1
Brown, R; Kaye, SB; Plumb, JA; Sludden, J; Strathdee, G1
Baker, TR; Caglar, H; Piedmonte, M; Piver, MS1
Shackney, S; Simon, SR; Uhl, M; Wang, SE1
Fanning, J; Piver, MS; Tsukada, Y; Zylstra, S1
Koĭnov, K; Marinov, L; Tsekova, V; Velikova, M1

Reviews

1 review(s) available for dacarbazine and Cancer of Ovary

ArticleYear
Complete response after MAID treatment for advanced primary ovarian angiosarcoma: case report and literature review.
    European journal of gynaecological oncology, 2014, Volume: 35, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms

2014

Trials

1 trial(s) available for dacarbazine and Cancer of Ovary

ArticleYear
A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer.
    Gynecologic oncology, 2004, Volume: 93, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Epithelial Cells; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Temozolomide

2004

Other Studies

20 other study(ies) available for dacarbazine and Cancer of Ovary

ArticleYear
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
    Cancer medicine, 2021, Volume: 10, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cardiovascular Diseases; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Doxorubicin; Female; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Polyethylene Glycols; Product Surveillance, Postmarketing; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Stroke Volume; Trabectedin; Ventricular Function, Left; Young Adult

2021
NEO212 induces mitochondrial apoptosis and impairs autophagy flux in ovarian cancer.
    Journal of experimental & clinical cancer research : CR, 2019, Jun-07, Volume: 38, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagosomes; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Disease Models, Animal; DNA Damage; Female; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Ovarian Neoplasms; Protein Transport; Xenograft Model Antitumor Assays

2019
PARP inhibitors and cancer therapy - early results and potential applications.
    The British journal of radiology, 2008, Volume: 81 Spec No 1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dacarbazine; Enzyme Inhibitors; Female; Humans; Melanoma; Mice; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide

2008
Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Dacarbazine; DNA Repair; Dose-Response Relationship, Drug; Female; Humans; O(6)-Methylguanine-DNA Methyltransferase; Oligonucleotides; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Temozolomide; Tetrazolium Salts; Thiazoles; Thionucleotides; Time Factors; Up-Regulation

2004
Pharmacokinetic model-predicted anticancer drug concentrations in human tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-01, Volume: 10, Issue:23

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Computer Simulation; Cyclohexanes; Dacarbazine; Female; Humans; Male; Models, Biological; O-(Chloroacetylcarbamoyl)fumagillol; Ovarian Neoplasms; Predictive Value of Tests; Rats; Rats, Inbred F344; Rats, Nude; Sesquiterpenes; Temozolomide; Topotecan; Transplantation, Heterologous; Vascular Endothelial Growth Factor A

2004
Primary angiosarcoma of the ovary: a case report of Stage I disease.
    Gynecologic oncology, 2005, Volume: 99, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mesna; Neoplasm Staging; Ovarian Neoplasms

2005
Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
    Cancer research, 2005, Nov-15, Volume: 65, Issue:22

    Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Dacarbazine; DNA Glycosylases; Female; Genetic Vectors; HeLa Cells; Humans; Methyl Methanesulfonate; Ovarian Neoplasms; RNA Interference; RNA, Small Interfering; Temozolomide; Ultraviolet Rays; Uterine Cervical Neoplasms

2005
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Jan-01, Volume: 13, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Base Sequence; Cell Line, Tumor; Dacarbazine; DNA Damage; DNA Glycosylases; DNA Repair; Dose-Response Relationship, Drug; Female; Humans; Hydroxylamines; Molecular Sequence Data; Ovarian Neoplasms; Temozolomide

2007
Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
    Cancer research, 1983, Volume: 43, Issue:12 Pt 1

    Topics: Animals; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Line; Cyclophosphamide; Dacarbazine; Drug Resistance; Female; Lymphoma, Large B-Cell, Diffuse; Melphalan; Mice; Mice, Inbred C57BL; Ovarian Neoplasms

1983
Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
    Gynecologic oncology, 1982, Volume: 14, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Prospective Studies; Sarcoma; Uterine Neoplasms; Vincristine

1982
Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
    Gynecologic oncology, 1995, Volume: 58, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Mesna; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Sarcoma; Treatment Outcome

1995
[Adjuvant chemotherapy in ovarian carcinoma. Preliminary results].
    Akusherstvo i ginekologiia, 1993, Volume: 32, Issue:1

    Topics: Adnexa Uteri; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bulgaria; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dacarbazine; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Vincristine

1993
[The role of glutathione and glutathione-S-transferase in neoplasm drug resistance].
    Biulleten' eksperimental'noi biologii i meditsiny, 1998, Volume: 125, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Erythrocytes; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Male; Melanoma; Ovarian Neoplasms; Propionates; Skin Neoplasms; Testicular Neoplasms

1998
Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3.
    Biochemical pharmacology, 1999, Apr-01, Volume: 57, Issue:7

    Topics: Alkylation; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Azepines; Base Sequence; Binding Sites; Cell Cycle; Cell Division; Cell Survival; Dacarbazine; DNA Damage; DNA, Neoplasm; Female; Guanine; Humans; Ovarian Neoplasms; Plasmids; RNA, Neoplasm; Structure-Activity Relationship; Temozolomide; Tumor Cells, Cultured

1999
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Colonic Neoplasms; Dacarbazine; Drug Synergism; Enzyme Inhibitors; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Temozolomide; Topotecan; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
    Cancer research, 2000, Nov-01, Volume: 60, Issue:21

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Base Pair Mismatch; Carboplatin; Carrier Proteins; Cisplatin; Colonic Neoplasms; Dacarbazine; Decitabine; DNA Methylation; DNA Repair; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Ovarian Neoplasms; Promoter Regions, Genetic; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2000
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
    American journal of clinical oncology, 1991, Volume: 14, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Female; Humans; Leukocyte Count; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platelet Count; Prospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms

1991
Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine.
    Gynecologic oncology, 1991, Volume: 41, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Pelvis; Tomography, X-Ray Computed

1991
Pathologic complete response of advanced ovarian mixed mesodermal tumor to cisplatin, adriamycin and dacarbazine: a case report.
    European journal of gynaecological oncology, 1989, Volume: 10, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms

1989
[Comparative research on different treatment regimens in disseminated cancer of the ovaries].
    Akusherstvo i ginekologiia, 1987, Volume: 26, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Remission Induction

1987
chemdatabank.com